Mar 05, 2020
Plaque Modification Devices Market to Reach US$ 2.1 Bn by 2027: TMR
Oct 22, 2019
Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis
Sep 30, 2019
"Good" Cholesterol Counters Atherosclerosis in Mice with Diabetes
Sep 25, 2019
SVS: 5 things you need to know about leg artery disease
May 17, 2019
Elucid Bioimaging Announces Notice of Award
Feb 21, 2019
Arterez Introduces a Novel, Triple-Compound Oral Therapy and Diagnostic Panels Targeting The Multi-Factorial 'Root-Causes' of Cardiovascular Disease - Not Cholesterol - in Human Studies
Jan 17, 2019
Swiss Enrollment Begins for FLEX Vessel Preparation System: The BELONG Study
Nov 13, 2018
Global Genomics Group (G3) Presents Data for the First Time on the Exact Size of Lipoprotein (a) Particles that Cause Plaque Buildup in Coronary Arteries from its GLOBAL Clinical Study Platform
Oct 31, 2018
Journal of Lipid Research names new editors-in-chief
Mar 28, 2018
Tasigna Lawsuits Mount, as Plaintiff in Washington State Accuses Novartis of Failing to Warn that Leukemia Drug Had Been Linked to Atherosclerosis-Related Conditions, Bernstein Liebhard LLP Reports
Mar 23, 2018
CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors
Feb 05, 2018
'Poor circulation' leads to worse outcomes in African American vascular patients
Jan 18, 2018
BaleDoneen Method Experts Discuss President Trump and the Deadly Myth of "Nonclinical" Heart Disease
Nov 29, 2017
CT Shows Enlarged Aortas in Former Pro Football Players
Nov 13, 2017
Novartis canakinumab (ACZ885) reduced cardiovascular risk by 25% in subgroup of CANTOS Phase III trial participants
Nov 13, 2017
Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments
Oct 23, 2017
New Research Identifies Health Disparities Among Adults with Familial Hypercholesterolemia (FH)
Oct 03, 2017
TV Icon and Heart Disease Survivor Regis Philbin Joins Kowa Pharmaceuticals America, Inc. to Launch National Education Campaign "Take Cholesterol to Heart"
Sep 13, 2017
Final Five Unpublished Vascular Clinical Trial Results Announced At VIVA 17
Aug 28, 2017
DalCor Achieves 50 percent Enrollment Milestone for Phase 3 Cardiovascular Trial